Crossmark

Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome

Crossref DOI link: https://doi.org/10.1038/s41591-018-0338-6

Published Online: 2019-02-18

Published Print: 2019-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Santiago-Fernández, Olaya

Osorio, Fernando G.

Quesada, Víctor https://orcid.org/0000-0002-8398-3457
Rodríguez, Francisco

Basso, Sammy

Maeso, Daniel

Rolas, Loïc

Barkaway, Anna

Nourshargh, Sussan

Folgueras, Alicia R.

Freije, José M. P. https://orcid.org/0000-0002-4688-8266
López-Otín, Carlos https://orcid.org/0000-0001-6964-1904
License Information

Text and Data Mining valid from 2019-02-18
More Information

Article History

Received: 22 January 2018

Accepted: 18 December 2018

First Online: 18 February 2019

Competing interests

: The authors declare no competing interests.